Europe
Sanofi will write a check for $40 million upfront.
Dr Barron was Executive VP, Head of Global Product Development, and CMO of Roche, responsible for all the products in the combined portfolio of Roche and Genentech.
CMV is a common and potentially serious viral infection in allogeneic HSCT recipients.
Fresh off the heels of a $201M liver disease R&D deal with Dicerna, Boehringer Ingelheim has struck another deal targeting liver disease with MiNA Therapeutics.
With worldwide spending on prescription drugs increasing from an estimated $774B in 2017 to over $1 trillion in 2022, a rising tide of pharmaceutical sales is lifting a lot of drug company boats and creating plenty of opportunities for investors.
The jobs are being cut because Roche is moving Swiss packaging ops to CMO-divested sites.
Harris fired the first shots on Monday.
Two of the top companies in the field are German-based CureVac and U.S.-based Moderna Therapeutics.
The SAB includes experts in vaccines and preventative health from leading academic/ research and international health organisations in the US and Europe.
‘Our track record in R&D was not great for a few years...’
PRESS RELEASES